Caries Inhibitory Effect of Nano Silver and Tri Calcium Phosphate Varnishes Among Visually Impaired Children
- Conditions
- Dental Caries
- Interventions
- Drug: Nano silver fluoride varnish and tri calcium phosphate varnish
- Registration Number
- NCT06576960
- Lead Sponsor
- Hadeer Mohammed Abd El wahab
- Brief Summary
- Assessment of pH,streptococcus mutants count, lactobacillus count and immunoglobulin A among visually impaired children after nano silver varnish application it tri calcium phosphate phosphate varnish application 
- Detailed Description
- Sixty children will be randomly divided into three equal treatment groups, composed of 20 children each, according to the type of material used as follows: 
 * Group I: children will receive oral health education and nano silver fluoride varnish.
 * Group II: children will receive oral health education and tri calcium phosphate varnish.
 * Group III: children will receive oral health education
 for all children ,Assessment of pH, streptococcus mutants count, lactobacillus count and immunoglobulin A will be assessed at baseline, one day , 3 months and 6 months after application
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Visually impaired children
- uncooperative children or children not willing to participate in the study.
- Children with systemic diseases
- Children with bronchial asthma.
- Children who were on antibiotic or medications that might affect oral flora or salivary flow taken within the previous 3 months
- History of fluoride treatment in the past 3-4 weeks.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
- Group - Intervention - Description - nano silver varnish - Nano silver fluoride varnish and tri calcium phosphate varnish - new fluoride varnish - tri calcium phosphate varnish - Nano silver fluoride varnish and tri calcium phosphate varnish - fluoride varnish contain calcium phosphate 
- Primary Outcome Measures
- Name - Time - Method - Salivary PH - 6 months - Salivary power of hydrogen at baseline, one month, 3months and six months after intervention - Lactobacillus count - 6 months - Count of bacteria at baseline, one day, 3months and six months after intervention - Immunoglobulin A - 6months - Level of immunoglobulin A at saliva at baseline, one day, 3months and 6 months after intervention - Salivary streptococcus mutants count - 6months - Count of bacteria at baseline, one day, 3months and six months after intervention 
- Secondary Outcome Measures
- Name - Time - Method 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
- Faculty of dentistry 🇪🇬- Tanta, Tanta City, Egypt Faculty of dentistry🇪🇬Tanta, Tanta City, Egypt
